Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma

Endocrine-Related Cancer

Volumn 23, Issue 2, 2016, Pages 65-76

  Chuffa, Luiz Gustavo A ^a   Alves, Michelly S ^a   Martinez, Marcelo ^b   Camargo, Isabel Cristina C ^a   Pinheiro, Patricia F F ^a   Domeniconi, Raquel F ^a   Júnior, Luiz Antonio L ^a   Martinez, Francisco Eduardo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Anti apoptotic protein; Melatonin; Ovarian cancer; Pro apoptotic protein

Indexed keywords

CASPASE 3; DNA; KI 67 ANTIGEN; MELATONIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SURVIVIN; BIRC5 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CALORIC INTAKE; CANCER SIZE; CANCER SURVIVAL; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; NONHUMAN; OVARY CARCINOMA; PROTEIN EXPRESSION; RAT; UPREGULATION; WEIGHT GAIN; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; MELATONIN; MICROTUBULE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84956833738     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-15-0463     Document Type: Article

References (42)

1. Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, Stewart C, Fereday S, Caldas C, Defazio A et al. 2010 Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. Journal of Pathology 221 49-56. (doi:10.1002/path.2696)
2. Batista AP, Silva TG, Teixeira AA, Medeiros PL, Teixeira VW, Alves LC & Santos FA 2013 Melatonin effect on the ultrastructure of Ehrlich ascites tumor cells, lifetime and hispathology in swiss mice. Life Sciences 93 882-888. (doi:10.1016/j.lfs.2013.10.012)
3. Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E & Sauer LA 2011 Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. Journal of Pineal Research 51 259-269. (doi:10.1111/j.1600-079X.2011.00888.x)
4. Cannistra SA 2004 Cancer of the ovary. New England Journal of Medicine 351 2519-2565. (doi:10.1056/NEJMra041842)
5. Chen R, Alvero AB, Silasi DA, Steffensen KD & Mor G 2008 Cancers take their Toll - The function and regulation of Toll-like receptors in cancer cells. Oncogene 27 225-233. (doi:10.1038/sj.onc.1210907)
6. Chuffa LG, Seiva FR, Fávaro WJ, Teixeira GR, Amorim JP, Mendes LO, Fioruci BA, Pinheiro PF, Fernandes AA, Franci JA et al. 2011a Melatonin reduces LH, 17b-estradiol and induces differential regulation of sex steroid receptors in reproductive tissues during rat ovulation. Reproductive Biology and Endocrinology 9 108. (doi:10.1186/1477-7827-9-108)
7. Chuffa LG, Amorim JP, Teixeira GR, Mendes LO, Fioruci BA, Pinheiro PF, Seiva FR, Novelli EL, Mello Júnior W, MartinezMet al. 2011b Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat. Brazilian Journal of Medical and Biological Research 44 217-223. (doi:10.1590/S0100- 879X2011007500018)
8. Chuffa LG, Fioruci-Fontanelli BA, Mendes LO, Fávaro WJ, Pinheiro PF, Martinez M & Martinez FE 2013a Characterization of chemically induce ovarian carcinomas in an ethanol-preferring rat model: Influence of long-term melatonin treatment. PLoS ONE 8 e81676. (doi:10.1371/journal.pone.0081676)
9. Chuffa LG, Seiva FR, Fávaro WJ, Amorim JP, Teixeira GR, Mendes LO, Fioruci-Fontanelli BA, Pinheiro PF, Martinez M & Martinez FE 2013b Melatonin and ethanol intake exert opposite effects on circulating estradiol and progesterone and differentially regulate sex steroid receptors in the ovaries, oviducts, and uteri of adult rats. Reproductive Toxicology 39 40-49. (doi:10.1016/j.reprotox.2013.04.001)
10. Chuffa LG, Fioruci-Fontanelli BA, Mendes LO, Ferreira Seiva FR,Martinez M, Fávaro WJ, Domeniconi RF, Pinheiro PF, Delazari Dos Santos L & Martinez FE 2015 Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer. BMC Cancer 15 34. (doi:10.1186/s12885-015-1032-4)
11. Cos S, Mediavilla MD, Fernández R, González-Lamuño D & Sánchez-Barceló EJ 2002 Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? Journal of Pineal Research 32 90-96. (doi:10.1034/j.1600-079x.2002.1821.x)
12. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH et al. 2002 Downregulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21 8843-8851. (doi:10.1038/sj.onc.1206044)
13. Fallows S, Price J, Atkinson RJ, Johnston PG, Hickey I & Russell SE 2001 P53 mutation does not affect prognosis in ovarian epithelial malignancies. Journal of Pathology 194 68-75. (doi:10.1002/path.857)
14. Fan L, Sun G,Ma T, Zhong F & WeiW2013 Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP. Journal of Pineal Research 55 174-185. (doi:10.1111/ jpi.12060)
15. Ferreira GM, Martinez M, Camargo IC, Domeniconi RF, Martinez FE & Chuffa LG 2014 Melatonin attenuates Her-2, p38 MAPK, p-AKT and mTOR levels in ovarian carcinoma of ethanol-preferring rats. Journal of Cancer 5 728-735. (doi:10.7150/jca.10196)
16. García-Navarro A, González-Puga C, Escames G, López LC, López A, López- Cantarero M, Camacho E, Espinosa A, Gallo MA & Acuña-Castroviejo D 2007 Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. Journal of Pineal Research 43 195-205. (doi:10.1111/j.1600-079X.2007.00463.x)
17. Hong Y, Won J, Lee Y, Lee S, Park K, Chang KT & Hong Y 2014 Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. Journal of Pineal Research 56 264-274. (doi:10.1111/jpi.12119)
18. Hoyer PB, Davis JR, Bedrnicek JB, Marion SL, Christian PJ, Barton JK & Brewer MA 2009 Ovarian neoplasm development by 7,12-dimethylbenz[ a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure. Gynecologic Oncology 112 610-615. (doi:10.1016/ j.ygyno.2008.12.013)
19. Jiang L, Luo RY, Yang J & Cheng YX 2013 Knockdown of contributes to antitumor activity in cisplatin-resistant ovarian cancer cells. Molecular Medicine Reports 7 425-430. (doi:10.3892/mmr.2012.1216)
20. Joo SS & Yoo YM 2009 Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: Therapeutic implications for prostate cancer. Journal of Pineal Research 47 8-14. (doi:10.1111/j.1600-079X.2009. 00682.x)
21. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T & Mor G 2006 TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Research 66 3859-3868. (doi:10.1158/0008-5472.CAN-05-3948)
22. Kim JH, Jeong SJ, Kim B, Yun SM, Choi do Y & Kim SH 2012 Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. Journal of Pineal Research 52 244-252. (doi:10.1111/ j.1600-079X.2011.00935.x)
23. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG & Reed JC 1994 Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology 145 1323-1326.
24. Li L, Chen DB, Lin C, Cao K, Wan Y, Zhao XY, Nie CL, Yuan Z & Wei YQ 2013 hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: Underlying action mechanism in ovarian cancer cells. Apoptosis 18 467-479. (doi:10.1007/s10495-012-0797-z)
25. Martín V, Herrera F, Carrera-Gonzalez P, García-Santos G, Antolín I, Rodriguez-Blanco J & Rodriguez C 2006 Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Research 66 1081-1088. (doi:10.1158/0008-5472. CAN-05-2354)
26. Martín-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andrés O, González P & González-Gallego J 2008 Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. Journal of Pineal Research 45 532-540. (doi:10.1111/j.1600-079X.2008.00641.x)
27. Mediavilla MD, Cos S & Sánchez-Barceló EJ 1999 Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sciences 65 415-420. (doi:10.1016/S0024-3205(99)00262-3)
28. O'Driscoll L, Linehan R & Clynes M2003 Survivin: Role in normal cells and in pathological conditions. Current Cancer Drug Targets 3 131-152. (doi:10.2174/1568009033482038)
29. Perdomo J, Cabrera J, Estévez F, Loro J, Reiter RJ & Quintana J 2013 Melatonin induces apoptosis through a caspase-dependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells. Journal of Pineal Research 55 195-206. (doi:10.1111/jpi.12062)
30. Reed JC 1997 Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in haematologic malignancies. Seminars in Hematology 34 9-19.
31. Reiter RJ 2004 Mechanisms of cancer inhibition by melatonin. Journal of Pineal Research 37 213-214. (doi:10.1111/j.1600-079X.2004.00165.x)
32. Rodriguez C, Martín V, Herrera F, García-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Sánchez-Sánchez AM, Suárez S, Puente-Moncada N, Anítua MJ et al. 2013 Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. International Journal ofMolecular Sciences 14 6597-6613. (doi:10.3390/ijms14046597)
33. Rubio S, Estévez F, Cabrera J, Reiter RJ, Loro J & Quintana J 2007 Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL 60 cells. Journal of Pineal Research 42 131-138. (doi:10.1111/j.1600-079X.2006.00392.x)
34. Salani R, Kurman RJ, Giuntoli R II, Gardner G, Bristow R, Wang TL & Shih IM 2008 Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. International Journal of Gynecological Cancer 18 487-491. (doi:10.1111/ j.1525-1438.2007.01039.x)
35. Stehle JH, Saade A, Rawashdeh O, Ackermann K, Jilg A, Sebestény T & Maronde E 2011 A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. Journal of Pineal Research 51 17-43. (doi:10. 1111/j.1600-079X.2011.00856.x)
36. Trubiani O, Recchioni R, Moroni F, Pizzicannella J, Caputi S & Di Primio R 2005 Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation. Journal of Pineal Research 39 425-431. (doi:10.1111/j.1600-079X.2005.00270.x)
37. Wong RS 2011 Apoptosis in cancer: From pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research 30 87. (doi:10.1186/ 1756-9966-30-87)
38. Wood PA, Yang X & HrusheskyWJ 2009 Clock genes and cancer. Integrative Cancer Therapies 8 303-308. (doi:10.1177/1534735409355292)
39. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM & Hrushesky WJ 2009 Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Research and Treatment 117 423-431. (doi:10.1007/s10549-008-0133-z)
40. Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IeM & Kurman RJ 2011 Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: An immunohistochemical and nucleotide sequencing analysis. Modern Pathology 24 1248-1253. (doi:10.1038/modpathol.2011.85)
41. Zeng T, Zhang CL, Song FY, Zhao XL, Yu LH, Zhu ZP & Xie KQ 2012 PI3K/AKT pathway activation was involved in acute ethanol-induced fatty liver in mice. Toxicology 296 56-66. (doi:10.1016/j.tox.2012. 03.005)
42. Zusman I, Gurevich P, Gurevich E & Ben-Hur H 2001 The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review). International Journal of Oncology 185 965-972. (doi:10.3892/ijo.18.5.965)